APP and Alzheimer disease: Persistent activation of Wnt signaling through Wnt ligands, or inhibition of negative regulators of Wnt signaling, such as Dickkopf-1 and GSK-3 beta are able to protect against Abeta toxicity and ameliorate cognitive performance in AD (Wan et al., 2014).